Endo Pharmaceuticals Gets a Thumbs Down and 4 More Analyst Downgrades to Know

Stock upgrades and downgrades are a controversial part of Wall Street. Despite regulations, many banks and firms still have a positive bias toward current clients and companies desired as future clients. In addition, Wall Street analysts are straight-up biased to the buy side. The percentage of sell recommendations is normally below 15 percent!

Regardless, upgrades and downgrades move stocks in the short-term. They fall into our CHEAT SHEET framework category ‘C = Catalyst for a Stock?s Movement’. Here are catalysts you must know today:

Endo Pharmaceuticals (NASDAQ:ENDP): Standpoint Research downgraded its rating on this company from Buy to Hold.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

endp

Expeditors International (NASDAQ:EXPD): Goldman Sachs downgraded its rating on this company from Conviction-Buy to Buy.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

expd

France Telecom SA (NYSE:FTE): Goldman Sachs downgraded its rating on this company from Sell to Conviction Sell.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

fte

Health Management Associates (NYSE:HMA): Deutsche Bank downgraded its rating on this company from Buy to Hold and changed its price target to $13.00.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

hma

InterDigital (NASDAQ:IDCC): William Blair downgraded its rating on this company from Outperform to Market Perform.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

idcc

Investing Insights: Will Pfizer Continue This Bullish Run?

More from The Cheat Sheet